Yukitaka Ueki Selected Research

Yukitaka Ueki Research Topics

Disease

61	Rheumatoid Arthritis 09/2022 - 04/2002
6	Type 2 Diabetes Mellitus (MODY) 03/2010 - 02/2002
5	Rheumatic Diseases (Rheumatism) 09/2022 - 01/2016
5	Infections 09/2022 - 06/2011
5	Neoplasms (Cancer) 06/2014 - 08/2010
4	Familial Mediterranean Fever (Periodic Disease) 09/2020 - 04/2016
3	Synovitis 09/2022 - 08/2012
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2022 - 08/2003
3	Stroke (Strokes) 03/2020 - 02/2002
3	Adult-Onset Still's Disease 09/2019 - 12/2017
3	Osteoporosis 05/2019 - 07/2011
3	Insulin Resistance 10/2008 - 02/2002
2	Edema (Dropsy) 09/2022 - 08/2012
2	Herpes Zoster 05/2021 - 01/2017
2	Fever (Fevers) 09/2020 - 08/2012
2	Genetic Predisposition to Disease (Genetic Predisposition) 09/2019 - 12/2017
2	Connective Tissue Diseases (Connective Tissue Disease) 11/2016 - 01/2015
2	Parkinson Disease (Parkinson's Disease) 06/2014 - 06/2014
2	Arthritis (Polyarthritis) 08/2012 - 04/2011
2	Inflammation (Inflammations) 04/2011 - 08/2003
2	Obesity 07/2002 - 02/2002
1	Immunoglobulin G4-Related Disease 01/2022
1	T-Cell Leukemia (Leukemia, T Cell) 09/2021
1	Sarcoidosis (Schaumann Disease) 11/2020
1	Vasculitis (Vasculitides) 11/2020
1	Cerebral Infarction 03/2020
1	Ischemic Stroke 03/2020
1	Thromboembolism 03/2020
1	Atrial Fibrillation 03/2020
1	HTLV-I Infections (HTLV-I Infection) 01/2018
1	Alcoholic Fatty Liver 01/2018
1	Macrophage Activation Syndrome 12/2017
1	Fasciitis (Fascitis) 11/2017
1	Myositis (Idiopathic Inflammatory Myopathies) 11/2017
1	Diabetes Mellitus 01/2017
1	Lung Diseases (Lung Disease) 01/2017
1	Takayasu Arteritis (Arteritis, Takayasu's) 12/2016
1	Pathologic Processes 11/2016
1	Bone Resorption 11/2016
1	Bone Fractures (Bone Fracture) 11/2016
1	Neutropenia 01/2016

Drug/Important Bio-Agent (IBA)

20	tocilizumab (atlizumab)FDA Link 01/2021 - 04/2011
18	Biological ProductsIBA 01/2022 - 01/2010
13	Methotrexate (Mexate)FDA LinkGeneric 05/2021 - 12/2010
10	Antirheumatic Agents (DMARD)IBA 01/2022 - 03/2014
8	Etanercept (Enbrel)FDA Link 01/2017 - 01/2009
7	Tumor Necrosis Factor InhibitorsIBA 09/2021 - 06/2011
6	tofacitinibIBA 01/2022 - 01/2017
6	Abatacept (Orencia)FDA Link 07/2021 - 09/2014
6	Pharmaceutical PreparationsIBA 05/2019 - 12/2002
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2021 - 12/2010
5	Biomarkers (Surrogate Marker)IBA 07/2021 - 09/2011
4	Infliximab (Remicade)FDA Link 12/2018 - 12/2011
3	E-SelectinIBA 03/2010 - 02/2002
2	SteroidsIBA 09/2022 - 12/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2022 - 08/2012
2	Janus Kinase InhibitorsIBA 03/2022 - 01/2021
2	HLA-DRB1 Chains (HLA DRB1)IBA 09/2019 - 12/2017
2	GlucocorticoidsIBA 05/2019 - 11/2016
2	CytokinesIBA 01/2018 - 04/2016
2	Interleukin-6 (Interleukin 6)IBA 11/2017 - 01/2014
2	Anti-Citrullinated Protein AntibodiesIBA 01/2017 - 10/2010
2	Adalimumab (Humira)FDA Link 01/2017 - 09/2011
2	Prednisolone (Predate)FDA LinkGeneric 01/2017 - 11/2016
2	Rheumatoid FactorIBA 08/2012 - 08/2011
2	Immunoglobulin M (IgM)IBA 08/2011 - 10/2010
2	SelectinsIBA 03/2010 - 02/2002
2	C-Reactive ProteinIBA 12/2006 - 08/2003
2	Insulin (Novolin)FDA Link 08/2003 - 02/2002
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 07/2002 - 02/2002
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 07/2002 - 02/2002
1	Conjugate VaccinesIBA 03/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	upadacitinibIBA 05/2021
1	baricitinibIBA 01/2021
1	16S Ribosomal RNAIBA 11/2020
1	ametantrone (HAQ)IBA 11/2020
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2020
1	NucleotidesIBA 09/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2020
1	HLA-DQB1 antigen (HLA DQB1)IBA 09/2019
1	Denosumab FDA Link 05/2019
1	Amyloid (Amyloid Fibrils)IBA 12/2018
1	InflammasomesIBA 12/2018
1	LipopolysaccharidesIBA 01/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Transaminases (Aminotransferases)IBA 01/2018
1	Interleukin-17 (Interleukin 17)IBA 12/2016
1	Diphosphonates (Bisphosphonates)IBA 11/2016
1	Vitamin D FDA LinkGeneric 11/2016
1	alfacalcidolIBA 11/2016
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 11/2016
1	Serum AlbuminIBA 01/2016
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2016

Therapy/Procedure

26	Therapeutics 09/2022 - 04/2002
2	Remission Induction 08/2011 - 01/2009
1	Renal Dialysis (Hemodialysis) 03/2020
1	Drug Tapering 12/2019